 |
|
Beta Pharma Inc. and Synergion Biotech Inc. signed a Collaboration Agreement on May of 2010. The field of collaboration is to cooperate business development including licensing transactions to support marketing business of Beta Pharma Inc's products. Currently, BetaPharma and Synergion are engaged in business development of Beta Pharma Inc's new drug Icotinib for treatment of non-small cell lung cancer. |
|
